Table 2.
Final pathological diagnosis results of CT-guided percutaneous FNA with or without ROSE.
| Result | ROSE group (ROSE results) | NO-ROSE group | |
|---|---|---|---|
| Not cancer | Inflammation | 30 (31) | 22 |
| Tuberculosis | 24 (34) | 19 | |
| Fungal infection | 3 (1) | 1 | |
| Atypical hyperplasia | 5 (2) | 1 | |
| Other | 6 (4) | 5 | |
|
| |||
| Malignancy | AC | 45 (34) | 34 |
| SCC | 11 (6) | 9 | |
| NSCLC-NOS | 1 (12) | 5 | |
| SCLC | 3 (3) | 1 | |
| Other | 4 (5) | 3 | |
|
| |||
| Benign | Hamartoma | 0 (0) | 2 |
|
| |||
| Total | 132 | 102 | |
AC: adenocarcinoma; SCC: squamous cell carcinoma; NSCLC-NOS: nonsmall cell lung cancer-not; SCLC: small cell lung cancer.